Effect of genotypic differences in CYP2C19 and on cure rates for Helicobacter pylori infection by triple therapy with different proton pump inhibitors
- Authors:
- K Demir, A Ormeci, Z Emrence, S Gokturk, B Baran, OM Soyer, F Akyuz, ...
- Journal:
- GASTROENTEROLOGY 144 (5), S333-S333
- Publication Year:
- 2013
- Citations:
- 1
- Subject Area:
- Mide Hastalıkları ve Helicobacter Pylori
Other Publications in This Subject Area
- Gastroesophageal reflux in asymptomatic patients with diabetes: an impedance study diabetes, obesity and gastroesophageal reflux (2020)
- Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism (2016)
- Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations? (2016)
- Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. (2016)
- The frequency of gastro-esophageal reflux disease in patients with mild-moderate stage chronic obstructive lung disease (COPD) and its relationship with acute exacerbations of COPD (2015)
This list was extracted from Prof. Dr. Çetin Karaca's public Google Scholar profile; DOI matches were verified against CrossRef. Citation counts reflect Google Scholar's data at extraction time and are not updated in real time.
← Back to Mide Hastalıkları ve Helicobacter Pylori publications